HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65

Diabetes

Volumn 53, Issue 7, 2004, Pages 1692-1699

  Tree, Timothy I M ^a   Duinkerken, Gaby ^b   Willemen, Sabine ^b   De Vries, René R P ^b   Roep, Bart O ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; HLA DQ ANTIGEN; INSULIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; PANCREAS ISLET; PRIORITY JOURNAL; SIBLING; T LYMPHOCYTE;

ALLELES; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; AUTOANTIGENS; CELL DIVISION; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISOENZYMES; MALE; T-LYMPHOCYTES; TETANUS TOXOID;

EID: 3042698353     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.7.1692     Document Type: Article

References (38)

1. Castano L, Eisenbarth GS: Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Ann Rev Immunol 8:647-679, 1990
2. Kolb H, Kolb-Bachofen V, Roep BO: Autoimmune versus inflammatory type I diabetes: a controversy? Immunol Today 16:170-172, 1995
3. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
4. Honeyman MC, Cram DS, Harrison LC: Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med 177:535-540, 1993
5. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL: T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 140:2569-2578, 1988
6. Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK, Christie MR, Roep BO: T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49:356-366, 2000
7. Worsaae A, Hejnaes K, Moody A, Ludvigsson J, Pociot F, Lorenzen T, Dyrberg T: T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity 22:183-189, 1995
8. Peakman M, Stevens EJ, Lohmann T, Narendran P, Dromey J, Alexander A, Tomlinson AJ, Trucco M, Gorga JC, Chicz RM: Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 104:1449-1457, 1999
9. Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA: Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus: report of the first international workshop for standardization of T cell assays. J Autoimmun 13:267-282, 1999
10. Viglietta V, Kent SC, Orban T, Hafler DA: GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 109:895-903, 2002
11. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987
12. McDevitt HO: The role of MHC class II molecules in susceptibility and resistance to autoimmunity. Curr Opin Immunol 10:677-681, 1998
13. Nepom BS, Nepom GT, Coleman M, Kwok WW: Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc Natl Acad Sci U S A 93:7202-7206, 1996
14. Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC: Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407-415, 1995
15. Altmann DM, Sansom D, Marsh SG: What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 12:267-270, 1991
16. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T: HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327:426-430, 1987
17. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, de Vries RR: T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes 44:278-283, 1995
18. Van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, De Vries RR: Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 19:213-216, 1989
19. Schreuder GM, Tilanus MG, Bontrop RE, Bruining GJ, Giphart MJ, van Rood JJ, de Vries RR: HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med 164:938-943, 1986
20. Durinovic-Bello I, Steinle A, Ziegler AG, Schendel DJ: HLA-DQ-restricted, islet-specific T-cell clones of a type 1 diabetic patient: T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 43:1318-1325, 1994
21. Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ: Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99:2405-2415, 1997
22. Reijonen H, Novak EJ, Kochik S, Heninger A, Liu AW, Kwok WW, Nepom GT: Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51:1375-1382, 2002
23. Legendre CM, Schiffrin A, Weitzner G, Colle E, Guttmann RD: Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus. Diabetes 37:792-795, 1988
24. Peakman M, Warnock T, Vats A, McNab GL, Underhill J, Donaldson PT, Vergani D: Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives. Diabetologia 37:155-165, 1994
25. Peakman M, Alviggi L, Hussain MJ, Lo SS, Hawa M, Leslie RD, Vergani D: Increased expression of T-cell markers of immunological memory associated with protection from type 1 diabetes: a study of identical twins. Diabetes 43:712-717, 1994
26. Gorga JC, Horejsi V, Johnson DR, Raghupathy R, Strominger JL: Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem 262:16087-16094, 1987
27. Cobbold S, Waldmann H: Infectious tolerance. Curr Opin Immunol 10:518-524, 1998
28. Walker LS, Abbas AK: The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2:11-19, 2002
29. Chatenoud L, Salomon B, Bluestone JA: Suppressor T cells: they're back and critical for regulation of autoimmunity! Immunol Rev 182:149-163, 2001
30. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA: Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391:177-181, 1998
31. Petersen LD, Duinkerken G, Bruining GJ, van Lier RA, de Vries RR, Roep BO: Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 9:731-737, 1996
32. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131-140, 2002
33. Peterson LD, van der Keur M, de Vries RR, Roep BO: Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia 42:443-449, 1999
34. Jordan MS, Riley MP, von Boehmer H, Caton AJ: Anergy and suppression regulate CD4(+) T cell responses to a self peptide. Eur J Immunol 30:136-144, 2000
35. Ishikura H, Ishikawa N, Aizawa M: Differential expression of HLA-class II antigens in the human thymus: relative paucity of HLA-DQ antigens in the thymic medulla. Transplantation 44:314-317, 1987
36. Douek DC, Altmann DM: T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus. Immunology 99:249-256, 2000
37. Sospedra M, Ferrer-Francesch X, Dominguez O, Juan M, Foz-Sala M, Pujol-Borrell R: Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J Immunol 161:5918-5929, 1998
38. Derbinski J, Schulte A, Kyewski B, Klein L: Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2:1032-1039, 2001